title: [Chemotherapy of bronchial carcinoma].
abstract: Antitumorous therapy comprises certain drugs of different origin. Scientific activities in discovering new antitumorous substances and making therapeutic schemes for achieving optimal effects have been presented worldwide for decades. The therapeutic effects are in the most cases very slight. Cured patients are rare, but this sometimes occurs. Partial reducing of tumorous infiltrate and its progression interruption appear more frequently. Therapeutic effectiveness manifests itself in improving of life-time quality. Regard of drug non-indifference and its limited effectiveness, the doctors must wonder about very sensitive question i.e. how much the drug administration will be of benefit or it will diminish this low life-time quality. Experts teams decide usually about drug administration. Early diagnosis is the "imperative" of present possibility appearance of symptoms to definitive treatment. The time from the beginning of the first therapy must be as short as possible if we wouldn't like to loose on therapy effectiveness.
authors.affiliation: Klinika za plućne bolesti, Klinicki centar Sarajevo.
authors.forename: Z
authors.initials: Z
authors.lastname: Dizdarević
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
vernacular_title: Hemoterapija karcinoma bronha.